🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Marina Baretti

Bloomberg (United States)

ORCID: 0000-0003-0125-2405

Also affiliated with Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Cancer Center, Johns Hopkins Hospital, Sidney Kimmel Comprehensive Cancer Center, University of Baltimore

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 14 papers. Top paper: “Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysis”.

Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysis

The Lancet Oncology(2024)10.1016/s1470-2045(24)00457-1
N/A
1.7DataRank · unranked
70 citations

Bernardo Stefanini, Julia Blanter, Benjamin Adegbite, Fionnuala Crowley, Vincent Yip +18 more

Entinostat in combination with nivolumab in metastatic pancreatic ductal adenocarcinoma: a phase 2 clinical trial

Nature Communications(2024)10.1038/s41467-024-52528-7
N/A
1.0DataRank · unranked
42 citations

Ludmila Danilova, Jennifer N. Durham, Courtney B. Betts, Leslie Cope, Dimitrios N. Sidiropoulos +19 more

An analysis of genetic heterogeneity in untreated cancers

Nature Reviews Cancer(2019)10.1038/s41568-019-0185-x
N/A
0.805DataRank · unranked
213 citations

Marina Baretti, Jeffrey M. Gerold, Alvin P. Makohon-Moore, Adil Daud, Christine A. Iacobuzio–Donahue +5 more

Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma

Nature Immunology(2024)10.1038/s41590-024-01992-w
N/A
0.695DataRank · unranked
102 citations

Won Jin Ho, Luciane T. Kagohara, Alexander A. Girgis, Sarah M. Shin, Ludmila Danilova +34 more

Pan-tumor analysis to investigate the obesity paradox in immune checkpoint blockade

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-009734
N/A
0.574DataRank · unranked
18 citations

Soren Charmsaz, Howard L. Li, Hua‐Ling Tsai, Ludmila Danilova, Kabeer Munjal +29 more

Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0072
N/A
0.529DataRank · unranked
33 citations

Mir Lim, Chester Kao, Daniel Shu, Amit G. Singal, Anne M. Noonan +7 more

Age-related divergence of circulating immune responses in patients with solid tumors treated with immune checkpoint inhibitors

Nature Communications(2025)10.1038/s41467-025-58512-z
N/A
0.510DataRank · unranked
29 citations

Soren Charmsaz, Hua‐Ling Tsai, Khaled Aziz, Daniel Shu, Kabeer Munjal +25 more

Immune-related events in individuals with solid tumors on immunotherapy associate with Th17 and Th2 signatures

Journal of Clinical Investigation(2024)10.1172/jci176567
N/A
0.500DataRank · unranked
27 citations

Soren Charmsaz, Stephanie Alden, Madelena Brancati, Howard L. Li, Aanika Balaji +38 more

Immune landscape of tertiary lymphoid structures in hepatocellular carcinoma (HCC) treated with neoadjuvant immune checkpoint blockade

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.16.562104
N/A
0.434DataRank · unranked
17 citations

Won Jin Ho, Luciane T. Kagohara, Alexander A. Girgis, Sarah M. Shin, Ludmila Danilova +29 more

Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial

Nature Communications(2026)10.1038/s41467-026-68324-4
N/A
0.416DataRank · unranked
15 citations

S. Daniel Haldar, Alexander A. Girgis, Hejia Wang, Ludmila Danilova, Thatcher Heumann +34 more

A therapeutic peptide vaccine for fibrolamellar hepatocellular carcinoma: a phase 1 trial

Nature Medicine(2025)10.1038/s41591-025-03995-y
N/A
0.302DataRank · unranked
6 citations

Allison M. Kirk, Brian H. Ladle, Zeal Kamdar, Kayla J. Bendinelli, Won Jin Ho +23 more

Anti-CTLA4 Therapy Leads to Early Expansion of a Peripheral Th17 Population and Induction of Th1 Cytokines

Cancer Immunology Research(2025)10.1158/2326-6066.cir-24-1055
N/A
0.292DataRank · unranked
6 citations

Soren Charmsaz, Elsa Hallab, Mike Fang, Chester Kao, Madelena Brancati +19 more

Data from Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma

(2023)10.1158/2767-9764.c.6719612.v2
N/A
0DataRank · unranked
0 citations

Mir Lim, Chester Kao, Daniel Shu, Amit G. Singal, Anne M. Noonan +7 more

Expanding the immunotherapy roadmap for hepatocellular carcinoma

Cancer Cell(2022)10.1016/j.ccell.2022.02.017
N/A
0DataRank · unranked
12 citations

Amy K. Kim, Robert A. Anders, Marina Baretti